The Role of SLC7A11 in Diabetic Wound Healing: Novel Insights and New Therapeutic Strategies

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2024 Sep 18

PMID 39290692

Authors

Wei Zhang

Jiawei Feng

Yiming Ni

Gen Li

Yuqing Wang

Yemin Cao

Mingmei Zhou

Cheng Zhao

Affiliations

Soon will be listed here.

Abstract

Diabetic wounds are a severe complication of diabetes, characterized by persistent, non-healing ulcers due to disrupted wound-healing mechanisms in a hyperglycemic environment. Key factors in the pathogenesis of these chronic wounds include unresolved inflammation and antioxidant defense imbalances. The cystine/glutamate antiporter SLC7A11 (xCT) is crucial for cystine import, glutathione production, and antioxidant protection, positioning it as a vital regulator of diabetic wound healing. Recent studies underscore the role of SLC7A11 in modulating immune responses and oxidative stress in diabetic wounds. Moreover, SLC7A11 influences critical processes such as insulin secretion and the mTOR signaling pathway, both of which are implicated in delayed wound healing. This review explores the mechanisms regulating SLC7A11 and its impact on immune response, antioxidant defenses, insulin secretion, and mTOR pathways in diabetic wounds. Additionally, we highlight the current advancements in targeting SLC7A11 for treating related diseases and conceptualize its potential applications and value in diabetic wound treatment strategies, along with the challenges encountered in this context.

References

Obrosova I . Update on the pathogenesis of diabetic neuropathy. Curr Diab Rep. 2003; 3(6):439-45. DOI: 10.1007/s11892-003-0005-1. View

Weichhart T, Hengstschlager M, Linke M . Regulation of innate immune cell function by mTOR. Nat Rev Immunol. 2015; 15(10):599-614. PMC: 6095456. DOI: 10.1038/nri3901. View

Long M, Rojo de la Vega M, Wen Q, Bharara M, Jiang T, Zhang R . An Essential Role of NRF2 in Diabetic Wound Healing. Diabetes. 2016; 65(3):780-93. PMC: 4764153. DOI: 10.2337/db15-0564. View

Wang X, Liu Z, Peng P, Gong Z, Huang J, Peng H . Astaxanthin attenuates osteoarthritis progression via inhibiting ferroptosis and regulating mitochondrial function in chondrocytes. Chem Biol Interact. 2022; 366:110148. DOI: 10.1016/j.cbi.2022.110148. View

Karam B, Chavez-Moreno A, Koh W, Akar J, Akar F . Oxidative stress and inflammation as central mediators of atrial fibrillation in obesity and diabetes. Cardiovasc Diabetol. 2017; 16(1):120. PMC: 5622555. DOI: 10.1186/s12933-017-0604-9. View

Blakytny R, Jude E . The molecular biology of chronic wounds and delayed healing in diabetes. Diabet Med. 2006; 23(6):594-608. DOI: 10.1111/j.1464-5491.2006.01773.x. View

Gan W, Dai X, Dai X, Xie J, Yin S, Zhu J . LATS suppresses mTORC1 activity to directly coordinate Hippo and mTORC1 pathways in growth control. Nat Cell Biol. 2020; 22(2):246-256. PMC: 7076906. DOI: 10.1038/s41556-020-0463-6. View

Li S, Li Y, Wu Z, Wu Z, Fang H . Diabetic ferroptosis plays an important role in triggering on inflammation in diabetic wound. Am J Physiol Endocrinol Metab. 2021; 321(4):E509-E520. DOI: 10.1152/ajpendo.00042.2021. View

Nakamura E, Sato M, Yang H, Miyagawa F, Harasaki M, Tomita K . 4F2 (CD98) heavy chain is associated covalently with an amino acid transporter and controls intracellular trafficking and membrane topology of 4F2 heterodimer. J Biol Chem. 1999; 274(5):3009-16. DOI: 10.1074/jbc.274.5.3009. View

10.

Kawahito S, Kitahata H, Oshita S . Problems associated with glucose toxicity: role of hyperglycemia-induced oxidative stress. World J Gastroenterol. 2009; 15(33):4137-42. PMC: 2738809. DOI: 10.3748/wjg.15.4137. View

11.

Zhang Y, Shi J, Liu X, Feng L, Gong Z, Koppula P . BAP1 links metabolic regulation of ferroptosis to tumour suppression. Nat Cell Biol. 2018; 20(10):1181-1192. PMC: 6170713. DOI: 10.1038/s41556-018-0178-0. View

12.

Jezek P, Holendova B, Jaburek M, Tauber J, Dlaskova A, Plecita-Hlavata L . The Pancreatic β-Cell: The Perfect Redox System. Antioxidants (Basel). 2021; 10(2). PMC: 7912581. DOI: 10.3390/antiox10020197. View

13.

Lei G, Zhuang L, Gan B . mTORC1 and ferroptosis: Regulatory mechanisms and therapeutic potential. Bioessays. 2021; 43(8):e2100093. DOI: 10.1002/bies.202100093. View

14.

Eming S, Martin P, Tomic-Canic M . Wound repair and regeneration: mechanisms, signaling, and translation. Sci Transl Med. 2014; 6(265):265sr6. PMC: 4973620. DOI: 10.1126/scitranslmed.3009337. View

15.

Sawaya A, Stone R, Brooks S, Pastar I, Jozic I, Hasneen K . Deregulated immune cell recruitment orchestrated by FOXM1 impairs human diabetic wound healing. Nat Commun. 2020; 11(1):4678. PMC: 7495445. DOI: 10.1038/s41467-020-18276-0. View

16.

Zhang Y, Swanda R, Nie L, Liu X, Wang C, Lee H . mTORC1 couples cyst(e)ine availability with GPX4 protein synthesis and ferroptosis regulation. Nat Commun. 2021; 12(1):1589. PMC: 7952727. DOI: 10.1038/s41467-021-21841-w. View

17.

Koppula P, Zhang Y, Zhuang L, Gan B . Amino acid transporter SLC7A11/xCT at the crossroads of regulating redox homeostasis and nutrient dependency of cancer. Cancer Commun (Lond). 2018; 38(1):12. PMC: 5993148. DOI: 10.1186/s40880-018-0288-x. View

18.

Yu X, Liu Z, Yu Y, Qian C, Lin Y, Jin S . Hesperetin promotes diabetic wound healing by inhibiting ferroptosis through the activation of SIRT3. Phytother Res. 2024; 38(3):1478-1493. DOI: 10.1002/ptr.8121. View

19.

Li T, Wang G . Computer-aided targeting of the PI3K/Akt/mTOR pathway: toxicity reduction and therapeutic opportunities. Int J Mol Sci. 2014; 15(10):18856-91. PMC: 4227251. DOI: 10.3390/ijms151018856. View

20.

Liu Y, Wang Y, Liu J, Kang R, Tang D . Interplay between MTOR and GPX4 signaling modulates autophagy-dependent ferroptotic cancer cell death. Cancer Gene Ther. 2020; 28(1-2):55-63. DOI: 10.1038/s41417-020-0182-y. View